SPSandra K. G. Peters

Sandra K. G. Peters

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sandra K. G. Peters has a total of 56 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Functional and transcriptional characterization of complex neuronal co-cultures

    by Heather A. Enright, Doris Lam, Aimy Sebastian, Ana Paula Sales, Jose Cadena, Nicholas R. Hum, Joanne J. Osburn, Sandra K. G. Peters, Bryan Petkus, David A. Soscia, et al.

    Brain-on-a-chip systems are designed to simulate brain activity using traditional in vitro cell culture on an engineered platform. It is a noninvasive tool to screen new drugs, evaluate toxicants, and elucidate disease mechanisms. However, successful recapitulation of brain function on these systems is dependent on the complexity of the cell culture. In this study, we increased cellular complexity of traditional (simple) neuronal cultures by co-culturing with astrocytes and oligodendrocyte precursor cells (complex culture). We evaluated and compared neuronal activity (e.g., network formation and maturation), cellular composition in long-term culture, and the transcriptome of the two cultures. Compared to simple cultures, neurons from complex co-cultures exhibited earlier synapse and network development and maturation, which was supported by localized synaptophysin expression, up-regulation of genes involved in mature neuronal processes, and synchronized neural network activity. Also, mature oligodendrocytes and reactive astrocytes were only detected in complex cultures upon transcriptomic analysis of age-matched cultures. Functionally, the GABA antagonist bicuculline had a greater influence on bursting activity in complex versus simple cultures. Collectively, the cellular complexity of brain-on-a-chip systems intrinsically develops cell type-specific phenotypes relevant to the brain while accelerating the maturation of neuronal networks, important features underdeveloped in traditional cultures.


  • Open Access

    Characterization of Bacillus anthracis Spore Proteins Using a Nanoscaffold Vaccine Platform

    by Dina R. Weilhammer, Alexis D. Dunkle, Tyler Boone, Sean F. Gilmore, Mark Khemmani, Sandra K. G. Peters, Paul D. Hoeprich, Nicholas O. Fischer, Craig D. Blanchette, Adam Driks, et al.

    Subunit vaccines are theoretically safe and easy to manufacture but require effective adjuvants and delivery systems to yield protective immunity, particularly at critical mucosal sites such as the lung. We investigated nanolipoprotein particles (NLPs) containing the Toll-like receptor 4 agonist monophosphoryl lipid A (MPLA) as a platform for intranasal vaccination against Bacillus anthracis. Modified lipids enabled attachment of disparate spore and toxin protein antigens. Intranasal vaccination of mice with B. anthracis antigen-MPLA-NLP constructs induced robust IgG and IgA responses in serum and in bronchoalveolar and nasal lavage. Typically, a single dose sufficed to induce sustained antibody titers over time. When multiple immunizations were required for sustained titers, specific antibodies were detected earlier in the boost schedule with MPLA-NLP-mediated delivery than with free MPLA. Administering combinations of constructs induced responses to multiple antigens, indicating potential for a multivalent vaccine preparation. No off-target responses to the NLP scaffold protein were detected. In summary, the NLP platform enhances humoral and mucosal responses to intranasal immunization, indicating promise for NLPs as a flexible, robust vaccine platform against B. anthracis and potentially other inhalational pathogens.


  • Open Access

    Tailoring HDL mimetics for in vivo delivery of mRNA

    by Wei He, Amy Rasley, Sean F. Gilmore, Sandra Peters, Matthew A. Coleman, Nicholas O. Fischer

    In vivo delivery of nucleic acid‐based therapeutics utilizing messenger RNA (mRNA) has significant implications for gene therapy, counteragent delivery, and vaccine applications. The mRNA therapeutics harness the body’s own cells to produce and deliver therapeutic protein molecules. However, large RNA molecules are prone to RNase degradation and exhibit marked difficulty in in vivo delivery compared with smaller RNA molecules. We have successfully engineered reconstituted high‐density lipoproteins (termed nanolipoprotein particles, NLPs) to deliver self‐amplifying mRNA (aka. Replicon) constructs in vivo . NLPs are nanometer‐scale, discoidal particles. They are safe, non‐immunogenic, and amenable to multiple routes of delivery. Also, the size and surface chemistry of NLPs allow for facile optimization of the delivery of compounds with wide range of physicochemical properties. To tailor NLPs for in vivo delivery of large nucleic acids molecules, a panel of NLPs formulated with a wide range of cationic lipids and assembly constituents were screened. Cationic lipids confer NLPs positive charge which successfully complexed with RNA Replicons encoding luciferase, provided protection from RNase degradation, and enhanced mRNA in vivo expression efficiency. These results represent the experimental foundation of utilizing the NLP technology to advance for RNA delivery. Future efforts focus on elucidating the correlation of NLP composition, NLP‐Replicon structure, and in vivo efficacy that will eventually allow for the rational design of a highly potent in vivo delivery platform that can be used as a universal mRNA delivery technology. Support or Funding Information: This work was performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE‐AC52‐07NA27344, through LDRD award 20‐ERD‐004. This work was also supported by U19 AI144184 from the National Institute of Allergy and Infectious Diseases


  • Open Access

    Cationic HDL mimetics enhance in vivo delivery of self-replicating mRNA

    by Wei He, Angela C. Evans, Amy Rasley, Feliza Bourguet, Sandra Peters, Kurt I. Kamrud, Nathaniel Wang, Bolyn Hubby, Martina Felderman, Heather Gouvis, et al.


  • Top Cited Papers
    Open Access

    A flexible 3-dimensional microelectrode array for in vitro brain models

    by David A. Soscia, Doris Lam, Angela C. Tooker, Heather Ann Enright, Michael Triplett, Piyush Karande, Sandra K. G. Peters, Ana Paula Sales, Elizabeth K. Wheeler, Nicholas O. Fischer

    A flexible 3D microelectrode array (3DMEA) device was developed that non-invasively interrogates electrophysiology of 3D in vitro neuronal cultures.


  • Open Access

    Optimizing cell encapsulation condition in ECM-Collagen I hydrogels to support 3D neuronal cultures

    by Doris Lam, Heather A. Enright, Sandra K.G. Peters, Monica L. Moya, David A. Soscia, Jose Cadena, Javier A. Alvarado, Kristen S. Kulp, Elizabeth K. Wheeler, Nicholas O. Fischer


  • Top Cited Papers
    Open Access

    Tissue-specific extracellular matrix accelerates the formation of neural networks and communities in a neuron-glia co-culture on a multi-electrode array

    by Doris Lam, Heather A. Enright, Jose Cadena, Sandra K. G. Peters, Ana Paula Sales, Joanne J. Osburn, David A. Soscia, Kristen S. Kulp, Elizabeth K. Wheeler, Nicholas O. Fischer

    The brain’s extracellular matrix (ECM) is a macromolecular network composed of glycosaminoglycans, proteoglycans, glycoproteins, and fibrous proteins. In vitro studies often use purified ECM proteins for cell culture coatings, however these may not represent the molecular complexity and heterogeneity of the brain’s ECM. To address this, we compared neural network activity (over 30 days in vitro) from primary neurons co-cultured with glia grown on ECM coatings from decellularized brain tissue (bECM) or MaxGel, a non-tissue-specific ECM. Cells were grown on a multi-electrode array (MEA) to enable noninvasive long-term interrogation of neuronal networks. In general, the presence of ECM accelerated the formation of networks without affecting the inherent network properties. However, specific features of network activity were dependent on the type of ECM: bECM enhanced network activity over a greater region of the MEA whereas MaxGel increased network burst rate associated with robust synaptophysin expression. These differences in network activity were not attributable to cellular composition, glial proliferation, or astrocyte phenotypes, which remained constant across experimental conditions. Collectively, the addition of ECM to neuronal cultures represents a reliable method to accelerate the development of mature neuronal networks, providing a means to enhance throughput for routine evaluation of neurotoxins and novel therapeutics.


  • Lipid composition dictates serum stability of reconstituted high-density lipoproteins: implications forin vivoapplications

    by Sean F. Gilmore, Timothy S. Carpenter, Helgi I. Ingólfsson, Sandra K. G. Peters, Paul T. Henderson, Craig D. Blanchette, Nicholas O. Fischer

    Nanolipoprotein particles (NLPs) are reconstituted high-density lipoproteins, consisting of a phospholipid bilayer stabilized by an apolipoprotein scaffold protein. This class of nanoparticle has been a vital tool in the study of membrane proteins, and in recent years has been increasingly used for in vivo applications. Previous work demonstrated that the composition of the lipid bilayer component affects the stability of these particles in serum solutions. In the current study, NLPs assembled with phosphatidylcholine lipids featuring different acyl chain structures were systematically tested to understand the effect that lipid composition has on NLP stability in both neat serum and cell culture media supplemented with 10% serum by volume. The time at which 50% of the particles dissociate, as well as the fraction of the initial population that remains resistant to dissociation, were correlated to key parameters obtained from all-atom simulations of the corresponding lipid bilayers. A significant correlation was observed between the compressibility modulus of the lipid bilayer and particle stability in these complex biological milieu. These results can be used as a reference to tune the stability of these versatile biological nanoparticles for in vitro and in vivo applications.


  • A preliminary assessment on the use of biochar as a soil additive for reducing soil-to-plant uptake of cesium isotopes in radioactively contaminated environments

    by Terry F. Hamilton, Roger E. Martinelli, Steven R. Kehl, Michael H. B. Hayes, Iris J. Smith, Sandra K. G. Peters, Michael W. Tamblin, Cindi L. Schmitt, Daniel Hawk